The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.
暂无分享,去创建一个
Michael P Boyle | Laura M Ensign | Jung Soo Suk | Justin Hanes | Samuel K Lai | J. S. Suk | J. Hanes | S. Lai | M. Boyle | P. Zeitlin | Ying-Ying Wang | L. Ensign | Ying-Ying Wang | Pamela L Zeitlin
[1] N A Peppas,et al. Surface modifications and molecular imprinting of polymers in medical and pharmaceutical applications. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[2] A. I. Yudin,et al. Diffusion of macromolecules and virus-like particles in human cervical mucus. , 2001, Biophysical journal.
[3] J. Suh,et al. Quantifying the Intracellular Transport of Viral and Nonviral Gene Vectors in Primary Neurons , 2007, Experimental biology and medicine.
[4] Denis Wirtz,et al. Micro- and macrorheology of mucus. , 2009, Advanced drug delivery reviews.
[5] P. Gilligan,et al. Patterns of Epithelial Cell Invasion by Different Species of the Burkholderia cepacia Complex in Well-Differentiated Human Airway Epithelia , 2002, Infection and Immunity.
[6] S. Smedt,et al. Cystic fibrosis sputum: a barrier to the transport of nanospheres. , 2000, American journal of respiratory and critical care medicine.
[7] N. Peppas,et al. Design of poly(ethylene glycol)-tethered copolymers as novel mucoadhesive drug delivery systems. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] Justin Hanes,et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus , 2007, Proceedings of the National Academy of Sciences.
[9] K. Braeckmans,et al. Three-dimensional fluorescence recovery after photobleaching with the confocal scanning laser microscope. , 2003, Biophysical journal.
[10] D. Geddes,et al. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium , 1999, Gene Therapy.
[11] Jung Soo Suk,et al. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. , 2008, Angewandte Chemie.
[12] D. Clarke,et al. Insertion of an Arginine Residue into the Transmembrane Segments Corrects Protein Misfolding* , 2006, Journal of Biological Chemistry.
[13] D. Wirtz,et al. Enhanced Viscoelasticity of Human Cystic Fibrotic Sputum Correlates with Increasing Microheterogeneity in Particle Transport* , 2003, Journal of Biological Chemistry.
[14] E. Fedorov,et al. Multiple-particle tracking measurements of heterogeneities in solutions of actin filaments and actin bundles. , 2000, Biophysical journal.
[15] Kevin B. Johnson,et al. Pharmacological Properties of N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N′-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis Lung Disease , 2008, Journal of Pharmacology and Experimental Therapeutics.
[16] B. Rubin. Other medications for aerosol delivery. , 2006, Paediatric respiratory reviews.
[17] S. Randell,et al. Evidence for Periciliary Liquid Layer Depletion, Not Abnormal Ion Composition, in the Pathogenesis of Cystic Fibrosis Airways Disease , 1998, Cell.
[18] T. Flotte,et al. Gene therapy in cystic fibrosis. , 1999, Chest.
[19] Russell M. Taylor,et al. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms , 2006, Proceedings of the National Academy of Sciences.
[20] T. Kirikae,et al. Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation. , 2005, Chest.
[21] M. Knowles,et al. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. , 2006, The New England journal of medicine.
[22] R. Boucher,et al. Cystic Fibrosis: The Mechanisms of Pathogenesis of an Inherited Lung Disorder. , 2007, Drug discovery today. Disease mechanisms.
[23] D. Leckband,et al. Direct Measurement of Interactions between Tethered Poly(ethylene glycol) Chains and Adsorbed Mucin Layers , 2002 .
[24] M. Drumm,et al. Cystic fibrosis. , 1996, American journal of respiratory and critical care medicine.
[25] D. Wirtz,et al. Efficient active transport of gene nanocarriers to the cell nucleus , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] D. Porteous,et al. Non-viral vectors in cystic fibrosis gene therapy: progress and challenges. , 2004, Trends in biotechnology.
[27] A. Hickey,et al. Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy. , 2002, Advanced drug delivery reviews.
[28] Junghae Suh,et al. Real-time multiple-particle tracking: applications to drug and gene delivery. , 2005, Advanced drug delivery reviews.
[29] S. Randell,et al. Reduced Three-Dimensional Motility in Dehydrated Airway Mucus Prevents Neutrophil Capture and Killing Bacteria on Airway Epithelial Surfaces1 , 2005, The Journal of Immunology.
[30] J. Voynow,et al. Respiratory tract mucin genes and mucin glycoproteins in health and disease. , 2006, Physiological reviews.
[31] J. Suh,et al. Gene Delivery to the Lung , 2003 .
[32] A. Hoffman,et al. Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[33] W. Saltzman,et al. DNA diffusion in mucus: effect of size, topology of DNAs, and transfection reagents. , 2006, Biophysical journal.
[34] A. Hickey,et al. Aerosol treatment of cystic fibrosis. , 2003, Critical reviews in therapeutic drug carrier systems.
[35] P. Noone,et al. Sodium channel blockers for cystic fibrosis. , 2006, The Cochrane database of systematic reviews.
[36] F. Ratjen,et al. Mucolytics in cystic fibrosis. , 2007, Paediatric respiratory reviews.
[37] P. Quinton. Physiological basis of cystic fibrosis: a historical perspective. , 1999, Physiological reviews.
[38] B. Amsden,et al. An Obstruction-Scaling Model for Diffusion in Homogeneous Hydrogels , 1999 .
[39] B. Laube,et al. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. , 2005, Respiratory care.
[40] A. Verkman,et al. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. , 2003, American journal of physiology. Cell physiology.
[41] J. Hanes,et al. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.
[42] James R. Smith,et al. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. , 2007, Pulmonary pharmacology & therapeutics.